Comparative Pharmacology
Head-to-head clinical analysis: PROTAMINE SULFATE versus VORAXAZE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROTAMINE SULFATE versus VORAXAZE.
PROTAMINE SULFATE vs VORAXAZE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Protamine sulfate is a cationic protein that binds to heparin, an anionic anticoagulant, forming a stable complex that neutralizes heparin's anticoagulant activity. It also has mild anticoagulant properties of its own.
Glucarpidase is a recombinant bacterial enzyme that hydrolyzes the glutamate residue from methotrexate and its metabolites, converting them to nontoxic metabolites.
1 mg IV per 100 units of heparin to be neutralized, administered slowly (not exceeding 5 mg/min) with continuous monitoring. Maximum single dose: 50 mg.
2000 units intravenously over 5 minutes as a single dose.
None Documented
None Documented
Complex with heparin: 4–5 minutes (free protamine: 7.4 minutes). Clinically, the anticoagulant reversal effect is rapid but may be transient due to heparin rebound.
Terminal elimination half-life is approximately 10 hours (range 6-16 hours) in patients with normal renal function. In patients with methotrexate-induced renal impairment, half-life may be prolonged up to 20-30 hours. Clinical context: the half-life determines the timing of repeat dosing or monitoring; a single dose typically reduces methotrexate levels by >97% within 15 minutes.
Primarily renal excretion (heparin-protamine complexes are cleared by the reticuloendothelial system; elimination is largely independent of renal function). <5% excreted unchanged in urine.
Voraxaze (glucarpidase) is a recombinant enzyme that rapidly cleaves circulating methotrexate into inactive metabolites (DAMPA and glutamate). It is not significantly renally or hepatically excreted; rather, it is a high-molecular-weight protein that is catabolized via proteolysis. The majority of the administered dose is metabolized and eliminated as smaller peptides and amino acids. Less than 1% is excreted unchanged in urine.
Category A/B
Category C
Antidote
Antidote